AN2 Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.82; its P/E ratio is -0.92; AN2 Therapeutics, Inc. is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.62. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -16.71M	$ -15.80M	$ -15.32M	$ -12.47M	$ -11.77M
EBITDA	-	$ -16.27M	$ -15.76M	$ -12.85M	$ -11.77M
Net Income Common Stockholders	$ -16.71M	$ -15.80M	$ -15.32M	$ -11.84M	$ -11.34M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 123.80M	$ 95.25M	$ 88.52M	$ 96.06M	$ 104.38M
Total Assets	$ 153.81M	$ 98.91M	$ 91.08M	$ 102.56M	$ 110.01M
Total Debt	$ 0.00	$ 13.00K	$ 34.00K	$ 53.00K	$ 73.00K
Net Debt	$ -123.80M	$ -95.23M	$ -88.48M	$ -96.01M	$ -104.31M
Total Liabilities	$ 14.84M	$ 11.16M	$ 8.57M	$ 7.19M	$ 4.43M
Stockholders Equity	$ 138.97M	$ 87.76M	$ 82.52M	$ 95.37M	$ 105.57M
Cash Flow	-
Free Cash Flow	-	$ -12.82M	$ -11.60M	$ -7.64M	$ -9.49M
Operating Cash Flow	$ -11.80M	$ -12.82M	$ -11.60M	$ -7.64M	$ -9.49M
Investing Cash Flow	$ -62.46M	$ 7.88M	$ 10.89M	$ 6.05M	$ -2.32M
Financing Cash Flow	$ 66.07M	$ 19.05M	$ 199.00K	-	$ -10.00K

Currency in USD

AN2 Therapeutics, Inc. Earnings and Revenue History

Income Statement >

AN2 Therapeutics, Inc. Debt to Assets

Balance Sheet >

AN2 Therapeutics, Inc. Cash Flow

Cash Flow >

AN2 Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing